Express Pharma

JANUARY 7, 2025

The 3rd edition of Pharma Live Expo & Summit will be held from April 17 to 19, 2025, at the Bombay Exhibition Centre, Mumbai. Pharma Live Expo & Summit 2025 provides a unique platform for stakeholders across the pharmaceutical value chain to come together, exchange knowledge, and drive impactful advancements.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing Packaging Hospitals 104

PharmaVoice

OCTOBER 1, 2024

Mark your calendars for the most important industry conferences in 2025.

253

253

The Pharmacist

DECEMBER 16, 2024

The eligible patient cohorts for vaccination under the spring 2025 Covid-19 programme have been confirmed, following recommendations from government advisors.

Vaccines 105

Vaccines Community Pharmacies 105

Med Ed 101

DECEMBER 22, 2024

I’ve put together an approximately 20-minute video on the BCMTMS exam and what you can expect for 2025. General information on the 2025 BCMTMS Exam Who writes the exam? About The BCMTMS Exam Content Domains […] The post 2025 BCMTMS Exam – How To Prepare? appeared first on Med Ed 101.

103

103

STAT

OCTOBER 4, 2024

That’s why the federal government expects enrollment in the $500 billion Medicare Advantage program to grow once again in 2025 — a stark contrast from insurers’ cries that modest payment reforms would damage them and seniors’ options.

Health Insurance Companies 347

Health Insurance Companies 347

Express Pharma

JANUARY 10, 2025

Looking ahead to 2025, were witnessing an industry in transformation. Looking ahead: What 2025 holds Supply chain management has come a long way from its humble beginnings. As we look to 2025, the focus must be on building supply chains that are not just efficient but also resilient, sustainable, and deeply aligned with patient needs.

Packaging 104

Packaging 104

The Pharmacist

JANUARY 28, 2025

Community Pharmacy Contractual Framework negotiations have now begun for the 2024/25 and 2025/26 funding agreements, the government has announced. Minister of state for care Stephen Kinnock […] The post BREAKING: Pharmacy contract negotiations begin for 2024/25 and 2025/26 appeared first on The Pharmacist.

Community Pharmacies 119

Community Pharmacies 119

STAT

APRIL 11, 2024

billion in 2025, a spokesperson for the Centers for Medicare and Medicaid Services confirmed to STAT. Medicare’s actuaries expect the drug Leqembi , made by the Japanese drugmaker Eisai and sold in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024, and the entire Medicare program $3.5

Documentation 363

Documentation 363

STAT

APRIL 1, 2024

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities.

Hospitals 363

Hospitals 363

The Pharmacist

MARCH 30, 2025

Community Pharmacy England has agreed a 3.073 billion Community Pharmacy Contractual Framework, in a new deal for the sector for 2025/26. The medicines margin for 2025/26 […] The post BREAKING: Community pharmacies get 3bn deal for 2025/26 appeared first on The Pharmacist.

Community Pharmacies 80

Community Pharmacies 80

Express Pharma

FEBRUARY 7, 2025

billion in January 2025, according to data from GlobalData. These three transactions accounted for 64 per cent of the total M&A deal value in January 2025. per cent in January 2025 compared to the same period last year. billion in Jan 2025 appeared first on Express Pharma. A total of 129 VC deals worth $4.5

Drug Development 97

Drug Development 97

STAT

MARCH 3, 2025

The company indicated that the investigation began in 2017 and picked up in intensity in late 2024 and early 2025.    The SEC filing states that on Feb.   Continue to STAT+ to read the full story…

350

350

STAT

APRIL 10, 2025

4, 2025 , implies that the oncologists in NCI’s Investigational Drug Branch (IDB) colluded with the drug company Exilixis to sponsor two Phase 3 studies of its drug cabozantanib. Mark Ratain’s First Opinion piece of Feb. Ratain concludes by recommending that IDB be abolished.

262

262

STAT

JANUARY 22, 2025

The committee  recommended  that the  2025-2030 Dietary Guidelines  “include more nutrient-dense plant-based meal and dietary recommendation options,” prioritize plant-based protein over animal protein, and center plain water, instead of dairy milk and soda, as a beverage of choice.

309

309

Express Pharma

JANUARY 19, 2025

Building upon the foundation laid by previous initiatives, the Union Budget 2025 could prioritise targeted incentives for AI in research and development, which will accelerate innovation in drug discovery, clinical trials, and personalised patient care.

Drug Development 103

Drug Development 103

Express Pharma

JANUARY 25, 2025

The Union Budget 2025-26 represents an opportunity for India to recalibrate policies that will drive the pharmaceutical sector forward as it approaches significant economic and industrial growth. In Conclusion, the Union Budget 2025-26 presents a key opportunity to boost Indias pharmaceutical sector.

Generic Medicine 76

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 76

STAT

APRIL 16, 2025

The DOJ began looking into the company in 2017, according to Semler, but re-upped its investigation in late 2024 and early 2025. The deal would cap an investigation Semler first disclosed in February into whether federal health programs paid out improper claims based on the use of QuantaFlo, which would violate the False Claims Act.

245

245

Express Pharma

JANUARY 7, 2025

To achieve this, the Union Budget 2025-2026 should prioritise innovation, ease of doing business, and policies that strengthen the Life Sciences Ecosystem. ” The post Association leaders share their expectations from Budget 2025-26 appeared first on Express Pharma. This will position India among the top 5 innovators and No.

105

105

Pharma Marketing Network

APRIL 2, 2025

In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability. In 2025, the ability to react to these preferences in near real time is what separates leading pharma marketing teams from the rest. FAQs What is the biggest trend in marketing in pharma in 2025?

Communication 64

Communication 64

Express Pharma

JANUARY 14, 2025

The post Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval pathways appeared first on Express Pharma.

105

105

Drug Channels

JANUARY 22, 2025

For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. In fact, nearly all marketed Humira biosimilars are excluded from the larger PBMs 2025 formularies. What do you think?

Biosimilars 98

Biosimilars Labelling 98

PharmaVoice

MARCH 10, 2025

Familiar foes in the industry have claimed a slew of jobs in recent months.

294

294

Drug Channels

APRIL 9, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. While some major companies have narrowed their focus or unwound previous integration efforts, ongoing consolidation and selective deconsolidation will continue to reshape the healthcare biome by trying to build something epic, block by block.

Specialty Pharmacies 98

Specialty Pharmacies 98

Express Pharma

JANUARY 14, 2025

The post Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends appeared first on Express Pharma. Todays consumers are more aware and proactive about their health and fitness levels and are seeking products that are not only effective but also to a large extent, tailored to their unique needs.

Diabetes 105

Diabetes Compounding 105

STAT

MARCH 13, 2025

At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. This was supposed to be the year of biotech’s comeback. Some foresaw a pickup in buyouts and initial public offerings, rewarding investors in the highly risky and cyclical business of bringing drugs to market.

273

273

Pharma Marketing Network

MARCH 27, 2025

The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Congratulations to the following honorees: 2025 HBA Rising Stars Jenn Wong Abbott Xongi Phaleng AbbVie Inc. We look forward to seeing you there! Vandana Rajakumar AbbVie Inc.

Communication 86

Communication 86

Express Pharma

APRIL 2, 2025

per cent to $79 million in March 2025, up from $43.5 million in February 2025. Truemeds and DCDC secured two of the largest funding rounds in March 2025, raising $44 million and $17.4 The post Pharma funding rises 81 per cent in march 2025, late-stage deals lead appeared first on Express Pharma. million, or 77.8

71

71

Express Pharma

MARCH 5, 2025

million in February 2025 from $ 300 million in January 2025. The decline in investment activity makes February 2025 one of the lowest-funded months in the past 12 months in the sector. MOC and Apex Kidney Care reported some of the biggest funding rounds in February 2025, raising $18 million and $9 million respectively.

66

66

Express Pharma

NOVEMBER 4, 2024

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk’s diabetes drug, liraglutide, to its platform in 2025. ” The post Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss medications appeared first on Express Pharma.

Compounding 105

Compounding Diabetes 105

Express Pharma

APRIL 16, 2025

The company stated that distribution will begin in May 2025. According to IQVIA sales data for the 12-month period ending February 2025, Adderall Tablets across the listed strengths recorded annual sales of approximately $421.7

66

66

Express Pharma

MARCH 2, 2025

The post Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation appeared first on Express Pharma.

Biosimilars 99

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 99

STAT

JUNE 10, 2024

The findings, disclosed in a press release, suggest the company may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025.

Immunity 360

Immunity Immunization Vaccines 360

PharmaVoice

JANUARY 6, 2025

How regulators could hit PBMs from multiple sides in the coming year.

325

325

STAT

FEBRUARY 12, 2024

You’re reading the web version of Health Care Inc.,    STAT’s weekly newsletter  following the flow of money in medicine.    Sign up  to get it in your inbox every Monday. 

Hospitals 337

Hospitals 337

Express Pharma

FEBRUARY 5, 2025

Model Ns 2025 State of Revenue Report reveals shifts toward use of generative AI and automation to bolster pharmaceutical, medtech, and high-tech revenue programs Model N published its seventh annual State of Revenue Report, highlighting how executives in these industries are transforming their revenue operations.

93

93

STAT

AUGUST 6, 2024

Alcohol policy researchers are fuming over a letter sent by members of Congress last month, which criticizes a panel of experts charged with assessing the health risks of drinking alcohol.

314

314

Drug Channels

NOVEMBER 7, 2024

Patient Support Programming in 2025 and Beyond. He then outlines three actions that should guide manufacturers' preparation. To learn more, register for ConnectiveRx’s free webinar on December 11: The Perfect Storm? Read on for Chris’s insights. All rights reserved. This Feed is for personal non-commercial use only.

97

97